151 related articles for article (PubMed ID: 17507719)
1. Prostate gland: MR imaging appearance after vascular targeted photodynamic therapy with palladium-bacteriopheophorbide.
Haider MA; Davidson SR; Kale AV; Weersink RA; Evans AJ; Toi A; Gertner MR; Bogaards A; Wilson BC; Chin JL; Elhilali M; Trachtenberg J
Radiology; 2007 Jul; 244(1):196-204. PubMed ID: 17507719
[TBL] [Abstract][Full Text] [Related]
2. TOOKAD(®) Soluble vascular-targeted photodynamic (VTP) therapy: determination of optimal treatment conditions and assessment of effects in patients with localised prostate cancer.
Azzouzi AR; Barret E; Moore CM; Villers A; Allen C; Scherz A; Muir G; de Wildt M; Barber NJ; Lebdai S; Emberton M
BJU Int; 2013 Oct; 112(6):766-74. PubMed ID: 24028764
[TBL] [Abstract][Full Text] [Related]
3. Vascular-targeted photodynamic therapy (padoporfin, WST09) for recurrent prostate cancer after failure of external beam radiotherapy: a study of escalating light doses.
Trachtenberg J; Weersink RA; Davidson SR; Haider MA; Bogaards A; Gertner MR; Evans A; Scherz A; Savard J; Chin JL; Wilson BC; Elhilali M
BJU Int; 2008 Aug; 102(5):556-62. PubMed ID: 18494829
[TBL] [Abstract][Full Text] [Related]
4. MR imaging of prostate after treatment with high-intensity focused ultrasound.
Kirkham AP; Emberton M; Hoh IM; Illing RO; Freeman AA; Allen C
Radiology; 2008 Mar; 246(3):833-44. PubMed ID: 18223121
[TBL] [Abstract][Full Text] [Related]
5. Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging.
Fütterer JJ; Heijmink SW; Scheenen TW; Veltman J; Huisman HJ; Vos P; Hulsbergen-Van de Kaa CA; Witjes JA; Krabbe PF; Heerschap A; Barentsz JO
Radiology; 2006 Nov; 241(2):449-58. PubMed ID: 16966484
[TBL] [Abstract][Full Text] [Related]
6. Hormonal ablation of prostatic cancer: effects on prostate morphology, tumor detection, and staging by endorectal coil MR imaging.
Chen M; Hricak H; Kalbhen CL; Kurhanewicz J; Vigneron DB; Weiss JM; Carroll PR
AJR Am J Roentgenol; 1996 May; 166(5):1157-63. PubMed ID: 8615261
[TBL] [Abstract][Full Text] [Related]
7. Prostate cancer: relationships between postbiopsy hemorrhage and tumor detectability at MR diagnosis.
Tamada T; Sone T; Jo Y; Yamamoto A; Yamashita T; Egashira N; Imai S; Fukunaga M
Radiology; 2008 Aug; 248(2):531-9. PubMed ID: 18539890
[TBL] [Abstract][Full Text] [Related]
8. Locally advanced rectal cancer: MR imaging for restaging after neoadjuvant radiation therapy with concomitant chemotherapy. Part II. What are the criteria to predict involved lymph nodes?
Lahaye MJ; Beets GL; Engelen SM; Kessels AG; de Bruïne AP; Kwee HW; van Engelshoven JM; van de Velde CJ; Beets-Tan RG
Radiology; 2009 Jul; 252(1):81-91. PubMed ID: 19403848
[TBL] [Abstract][Full Text] [Related]
9. Reducing metallic artifacts in postoperative spinal imaging: usefulness of IDEAL contrast-enhanced T1- and T2-weighted MR imaging--phantom and clinical studies.
Cha JG; Jin W; Lee MH; Kim DH; Park JS; Shin WH; Yi BH
Radiology; 2011 Jun; 259(3):885-93. PubMed ID: 21386053
[TBL] [Abstract][Full Text] [Related]
10. Detection of prostate cancer with magnetic resonance imaging: optimization of T1-weighted, T2-weighted, dynamic-enhanced T1-weighted, diffusion-weighted imaging apparent diffusion coefficient mapping sequences and MR spectroscopy, correlated with biopsy and histopathological findings.
Aydin H; Kizilgöz V; Tatar IG; Damar C; Ugan AR; Paker I; Hekimoğlu B
J Comput Assist Tomogr; 2012; 36(1):30-45. PubMed ID: 22261768
[TBL] [Abstract][Full Text] [Related]
11. MR imaging follow-up after percutaneous radiofrequency ablation of renal cell carcinoma: findings in 18 patients during first 6 months.
Merkle EM; Nour SG; Lewin JS
Radiology; 2005 Jun; 235(3):1065-71. PubMed ID: 15914485
[TBL] [Abstract][Full Text] [Related]
12. Rectal cancer: MR imaging in local staging--is gadolinium-based contrast material helpful?
Vliegen RF; Beets GL; von Meyenfeldt MF; Kessels AG; Lemaire EE; van Engelshoven JM; Beets-Tan RG
Radiology; 2005 Jan; 234(1):179-88. PubMed ID: 15550372
[TBL] [Abstract][Full Text] [Related]
13. Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging.
Engelbrecht MR; Huisman HJ; Laheij RJ; Jager GJ; van Leenders GJ; Hulsbergen-Van De Kaa CA; de la Rosette JJ; Blickman JG; Barentsz JO
Radiology; 2003 Oct; 229(1):248-54. PubMed ID: 12944607
[TBL] [Abstract][Full Text] [Related]
14. Endoscopic laser ablation of the prostate: MR appearances during and after treatment and their relation to clinical outcome.
deSouza NM; Flynn RJ; Coutts GA; Gilderdale DJ; Hall AS; Puni R; Chui M; Harris DN; Kiely EA
AJR Am J Roentgenol; 1995 Jun; 164(6):1429-34. PubMed ID: 7538727
[TBL] [Abstract][Full Text] [Related]
15. Vascular targeted photodynamic therapy with palladium-bacteriopheophorbide photosensitizer for recurrent prostate cancer following definitive radiation therapy: assessment of safety and treatment response.
Trachtenberg J; Bogaards A; Weersink RA; Haider MA; Evans A; McCluskey SA; Scherz A; Gertner MR; Yue C; Appu S; Aprikian A; Savard J; Wilson BC; Elhilali M
J Urol; 2007 Nov; 178(5):1974-9; discussion 1979. PubMed ID: 17869307
[TBL] [Abstract][Full Text] [Related]
16. Hepatocellular carcinoma in the cirrhotic liver: gadolinium-enhanced 3D T1-weighted MR imaging as a stand-alone sequence for diagnosis.
Hecht EM; Holland AE; Israel GM; Hahn WY; Kim DC; West AB; Babb JS; Taouli B; Lee VS; Krinsky GA
Radiology; 2006 May; 239(2):438-47. PubMed ID: 16641353
[TBL] [Abstract][Full Text] [Related]
17. Brachytherapy for prostate cancer: endorectal MR imaging of local treatment-related changes.
Coakley FV; Hricak H; Wefer AE; Speight JL; Kurhanewicz J; Roach M
Radiology; 2001 Jun; 219(3):817-21. PubMed ID: 11376276
[TBL] [Abstract][Full Text] [Related]
18. Prostate cancer: evaluation of vascular characteristics with dynamic contrast-enhanced T1-weighted MR imaging--initial experience.
Buckley DL; Roberts C; Parker GJ; Logue JP; Hutchinson CE
Radiology; 2004 Dec; 233(3):709-15. PubMed ID: 15498903
[TBL] [Abstract][Full Text] [Related]
19. Effects of androgen deprivation on prostatic morphology and vascular permeability evaluated with mr imaging.
Padhani AR; MacVicar AD; Gapinski CJ; Dearnaley DP; Parker GJ; Suckling J; Leach MO; Husband JE
Radiology; 2001 Feb; 218(2):365-74. PubMed ID: 11161148
[TBL] [Abstract][Full Text] [Related]
20. Prostate tissue composition and MR measurements: investigating the relationships between ADC, T2, K(trans), v(e), and corresponding histologic features.
Langer DL; van der Kwast TH; Evans AJ; Plotkin A; Trachtenberg J; Wilson BC; Haider MA
Radiology; 2010 May; 255(2):485-94. PubMed ID: 20413761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
